Previous 10 | Next 10 |
2023-04-25 17:35:57 ET Icon ( NASDAQ: ICLR ) is scheduled to announce Q1 earnings results on Wednesday, April 26th, after market close. The consensus EPS Estimate is $2.87 (+4.0% Y/Y) and the consensus Revenue Estimate is $1.98B (+4.2% Y/Y). Over the last 2 years, ICLR...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the first quarter 2023 after the market closes on Wednesday, April 26, 2023. The company will hold a conference call and webcas...
LEO Pharma , a global leader in medical dermatology, and ICON plc (NASDAQ: ICLR) today announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective, and which will support the company’s overall ambition...
2023-03-06 09:29:44 ET Summary One name particularly appealing in the healthcare space is ICON Public Limited Company, a CRO (Contract Research Organization) that has delivered sustained revenue growth. While the macroeconomic environment is still unclear, the outlook for ICON see...
ICON plc , (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the 2023 Citi Healthcare Conference on Thursday, March 2, 2023 at 2pm ET. Dr. Steve Cutler, CEO of ICON plc, wi...
ICON Public Limited Company (ICLR) Q4 2022 Earnings Conference Call February 23, 2023, 08:00 AM ET Company Participants Kate Haven - VP of IR Brendan Brennan - CFO Steve Cutler - CEO Conference Call Participants Sandy Draper - Guggenheim Justin Bowers -...
Icon press release ( NASDAQ: ICLR ): Q4 Non-GAAP EPS of $3.13 beats by $0.08 . Revenue of $1.96B (+3.7% Y/Y) in-line. For further details see: Icon Non-GAAP EPS of $3.13 beats by $0.08, revenue of $1.96B in-line
Highlights Net business wins in the quarter of $2,350 million; a net book to bill of 1.20. Full year net business wins of $9,450 million; a net book to bill of 1.22. Closing backlog in the quarter of $20.7 billion, an increase of 2.4% on quarter three 2022 or an increase of 8.7% on qu...
Summary ICON plc has set new highs after re-rating to the upside from late FY22. The company posted FY23E' guidance in January, where investors were swift to price in the growth forecasts. We believe there's scope for the stock to continue repricing higher. Net-net, revise to bu...
Summary Waters Corporation has been a source of relative stability over the past several months, with the company performing slightly better than the broader market. This comes as sales rise but also while profits and cash flows come under some pressure. If shares were cheaper, the ...
News, Short Squeeze, Breakout and More Instantly...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading business and industry awards recognising the company’s leadership position in the clinical research industry, in addi...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2024 after the market closes on Wednesday, July 24, 2024. The company will hold a conference call and webcas...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET. Any changes to this event and links...